$1,175.15
+2.46%
N/A+$28.25
Healthcare
Drug Manufacturers - General
NYSE
Active Trading
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 74.2% | 76.8% | 79.2% | 81.3% | 83.8% | — |
| Operating MarginOperating income as a percentage of revenue. | 28.0% | 30.3% | 31.6% | 38.9% | 45.6% | — |
| Net MarginNet income as a percentage of revenue. | 19.7% | 21.9% | 15.4% | 23.5% | 31.7% | — |
| EBITDA MarginEBITDA divided by revenue. | 28.4% | 30.3% | 25.1% | 33.8% | 42.9% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 21.7% | 23.8% | 19.2% | 28.2% | 39.5% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 1.23 | 1.05 | 0.94 | 1.15 | 1.58 | — |
| Quick RatioLiquid assets divided by current liabilities. | 0.97 | 0.80 | 0.73 | 0.89 | 1.19 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.25 | 0.12 | 0.10 | 0.12 | 0.20 | — |
| Debt / AssetsDebt as a share of total assets. | 34.6% | 32.8% | 39.4% | 42.7% | 37.8% | — |
| Debt / EquityDebt compared with shareholder equity. | 1.88 | 1.52 | 2.34 | 2.37 | 1.60 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 3.48x | 3.33x | 3.01x | 3.39x | 3.23x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 1.88x | 1.54x | 1.23x | 1.11x | 0.77x | — |
| Payables TurnoverHow often payables are paid in a year. | 4.38x | 3.43x | 2.73x | 2.61x | 1.96x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.58x | 0.58x | 0.53x | 0.57x | 0.58x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 6.76x | 13.29x | -101.88x | 32.21x | 5.26x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 47.22x | 55.68x | 99.99x | 65.65x | 46.73x | — |
| P/B RatioPrice paid for each dollar of book value. | 29.34x | 32.64x | 48.67x | 48.99x | 36.37x | — |
| P/S RatioPrice paid for each dollar of sales. | 9.30x | 12.18x | 15.36x | 15.44x | 14.81x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 48.89x | 75.56x | -166.33x | 1678.17x | 107.56x | — |
| Dividend YieldAnnual dividend divided by current share price. | 1.2% | 1.0% | 0.8% | 0.7% | 0.6% | — |